Marker Therapeutics (MRKR) Revenue (2010 - 2026)
Marker Therapeutics (MRKR) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Marker Therapeutics (MRKR) revenue is $3.94M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Marker Therapeutics (MRKR) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -30.88% |
| 3 Years TTM | +1.39% |
| 5 Years TTM | +53.00% |
Annual Revenue change of Marker Therapeutics (MRKR)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $750K | -78.87% |
| 2025 | $3.55M | -46.13% |
| 2024 | $6.59M | +99.09% |
| 2023 | $3.31M | -5.70% |
| 2022 | $3.51M | +183.06% |
| 2021 | $1.24M | +163.83% |
| 2020 | $470K | +123.81% |
| 2019 | $210K | N/A |
| 2018 | $210K | +16.67% |
| 2017 | $180K | N/A |
| 2016 | $0 | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | -100.00% |
| 2012 | -$6.22M | +87.35% |
| 2011 | -$3.32M | N/A |
| 2010 | $0 | N/A |
| 2009 | $0 | N/A |
| 2008 | $0 | N/A |
| 2007 | $0 | N/A |
| 2006 | $0 | N/A |
| 2005 | $0 | N/A |
| 2004 | $0 | N/A |
| 2003 | $0 | N/A |
| 2002 | $0 | N/A |
| 2001 | $0 | N/A |
| 2000 | $0 | N/A |
Comparison Marker Therapeutics (MRKR) five years revenue CAGR with competitors
Marker Therapeutics (MRKR) five years revenue CAGR is 53.28%.